Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia

Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia

Immunotherapy has without question revolutionized the treatment of both hematologic and solid malignancies. Over the last several years novel strategies are being developed to incorporate these groundbreaking therapies into the care of patients with AML. Here we present an overview of the recent dev...

Full description

Bibliographic Details
Main Authors: Kyle Wiatrowski, Tae Hee Kim, Amanda Przespolewski
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
acute myeloid leukaemia
immunotherapy
biomarkers
checkpoint inhibition
T cell directed therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.826768/full

Similar Items

Similar Items